Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today that they will work together to develop clinical applications of ...
Leading GMP cell therapy CDMO I Peace, Inc. ( specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that it has successfully generated human induced ...
Hosted on MSN
Japan's iPS Cell Breakthroughs Are Reshaping Regenerative Medicine and Parkinson's Treatment
“It is a significant achievement that we have been able to confirm improvement in patients’ symptoms,” Director of Kyoto University’s Center for iPS Cell Research and Application (CiRA) Jun Takahashi ...
I Peace will provide its GMP iPS cell-related technology to generate the MCB's for the parent line and the modified subclones, while Vita will provide the technology necessary for gene editing and ...
It’s been 16 years since scientists first coaxed skin cells back into their embryonic state, a development that made it possible to sidestep the thorny ethical dilemmas around sourcing human stem ...
A group of researchers in Japan says it has confirmed a certain level of efficacy in using iPS cell-derived immune cells for cancer treatment in a clinical trial. The group says it is the first time ...
Dr Sam Buckberry has received funding from the NHMRC and WA Department of Health. He is employed by the Telethon Kids Institute, is affiliated with the Australian National University and is on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results